Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ding Wang

Showing results (951-960 of 970) with videos related to

Pageof 97
Sort By:
British Journal of Haematology|September 30, 2024
TMEM56 deficiency impairs the haem metabolism and cell cycle progression during human erythropoiesisJingwei Wang, Yingnan Zhang, Jinhua Liu, et al.
Blood Advances|December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 studyGareth P Gregory, Shaji Kumar, Ding Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 26, 2018
High-Mobility Two-Dimensional Electron Gas at InGaN/InN Heterointerface Grown by Molecular Beam EpitaxyTao Wang, Xinqiang Wang, Zhaoying Chen, et al.
Science Advances|April 30, 2025
Ultralow-pressure mechanical-motion switching of ferroelectric polarizationBaoyu Wang, Xin He, Jianjun Luo, et al.
British Journal of Cancer|September 11, 2020
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancerMartin H Voss, Michael S Gordon, Monica Mita, et al.
Clinical Lung Cancer|March 22, 2021
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811)Athanassios Argiris, Jieling Miao, Mihaela C Cristea, et al.
Cell Stem Cell|February 23, 2021
Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative NeoplasmsJingyuan Tong, Ting Sun, Shihui Ma, et al.
BMC Cancer|November 3, 2023
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 studyDo-Youn Oh, Maria Alsina Maqueda, David I Quinn, et al.
Nature Communications|July 6, 2024
Erythroid-intrinsic activation of TLR8 impairs erythropoiesis in inherited anemiaJing Liang, Yang Wan, Jie Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2024
First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced MalignanciesNehal J Lakhani, Kyriakos P Papadopoulos, Melissa Lynne Johnson, et al.
Pageof 97

Showing results (951-960 of 970) with videos related to

Sort By:
Pageof 97
British Journal of Haematology|September 30, 2024
TMEM56 deficiency impairs the haem metabolism and cell cycle progression during human erythropoiesisJingwei Wang, Yingnan Zhang, Jinhua Liu, et al.
Blood Advances|December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 studyGareth P Gregory, Shaji Kumar, Ding Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 26, 2018
High-Mobility Two-Dimensional Electron Gas at InGaN/InN Heterointerface Grown by Molecular Beam EpitaxyTao Wang, Xinqiang Wang, Zhaoying Chen, et al.
Science Advances|April 30, 2025
Ultralow-pressure mechanical-motion switching of ferroelectric polarizationBaoyu Wang, Xin He, Jianjun Luo, et al.
British Journal of Cancer|September 11, 2020
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancerMartin H Voss, Michael S Gordon, Monica Mita, et al.
Clinical Lung Cancer|March 22, 2021
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811)Athanassios Argiris, Jieling Miao, Mihaela C Cristea, et al.
Cell Stem Cell|February 23, 2021
Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative NeoplasmsJingyuan Tong, Ting Sun, Shihui Ma, et al.
BMC Cancer|November 3, 2023
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 studyDo-Youn Oh, Maria Alsina Maqueda, David I Quinn, et al.
Nature Communications|July 6, 2024
Erythroid-intrinsic activation of TLR8 impairs erythropoiesis in inherited anemiaJing Liang, Yang Wan, Jie Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2024
First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced MalignanciesNehal J Lakhani, Kyriakos P Papadopoulos, Melissa Lynne Johnson, et al.
Pageof 97